SI
Shoulder InnovationsANYSE / Health Care Equipment & Services
Last Price
At close
2026-07-17
Current thesis
The best-supported bull case is that Q1 showed real commercial traction rather than a one-off beat: 65% revenue growth, 51% implant volume growth, higher ASP, margin expansion, and a raised full-year revenue outlook suggest the launch/commercial engine is working [#SEC-8K-2026-05-13].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -0.4.
What can break
Operating losses widened in Q1 2026 despite strong top-line growth, showing that commercial scale has not yet translated into operating leverage [#SEC-8K-2026-05-13].
Momentum
95
Value
44
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $21.75 · Bull $24.00 · Bear $15.00
Data freshness
Prices
As of 2026-07-17
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-17 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-11 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-17
Investment thesis
As of 2026-07-17
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $22.25
Why
Momentum95 · Δ7d -0.4
Value44 · Δ7d +0.0
Sentiment51 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
95
26% active weight
Current posture
7d trendSoftening
Δ7d
-0.4
Δ21d
+2.9
Value
44
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-1.0
Sentiment
51
34% active weight
Current posture
7d trendSoftening
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 95.2 / Value 44.0 / Sentiment 50.9
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$447.74M
Beta
-
Shares Out
20.74M
P/E (TTM) · Derived
-11.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-10.15
Rev YoY
+64.9%
EPS YoY
+73.4%
Gross Margin
+70.0%
Op Margin
-
Net Debt
-$109.28M
Current Ratio
11.81
As of 2026-07-17 • Updated nightlySource: Internal modelMethodology